B

Bangkok Lab and Cosmetic PCL
SET:BLC

Watchlist Manager
Bangkok Lab and Cosmetic PCL
SET:BLC
Watchlist
Price: 5.35 THB Market Closed
Market Cap: 3.2B THB
Have any thoughts about
Bangkok Lab and Cosmetic PCL?
Write Note

Intrinsic Value

The intrinsic value of one BLC stock under the Base Case scenario is 3.76 THB. Compared to the current market price of 5.35 THB, Bangkok Lab and Cosmetic PCL is Overvalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BLC Intrinsic Value
3.76 THB
Overvaluation 30%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Bangkok Lab and Cosmetic PCL

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BLC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BLC?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Bangkok Lab and Cosmetic PCL

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Bangkok Lab and Cosmetic PCL

Provide an overview of the primary business activities
of Bangkok Lab and Cosmetic PCL.

What unique competitive advantages
does Bangkok Lab and Cosmetic PCL hold over its rivals?

What risks and challenges
does Bangkok Lab and Cosmetic PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bangkok Lab and Cosmetic PCL.

Provide P/S
for Bangkok Lab and Cosmetic PCL.

Provide P/E
for Bangkok Lab and Cosmetic PCL.

Provide P/OCF
for Bangkok Lab and Cosmetic PCL.

Provide P/FCFE
for Bangkok Lab and Cosmetic PCL.

Provide P/B
for Bangkok Lab and Cosmetic PCL.

Provide EV/S
for Bangkok Lab and Cosmetic PCL.

Provide EV/GP
for Bangkok Lab and Cosmetic PCL.

Provide EV/EBITDA
for Bangkok Lab and Cosmetic PCL.

Provide EV/EBIT
for Bangkok Lab and Cosmetic PCL.

Provide EV/OCF
for Bangkok Lab and Cosmetic PCL.

Provide EV/FCFF
for Bangkok Lab and Cosmetic PCL.

Provide EV/IC
for Bangkok Lab and Cosmetic PCL.

Compare the intrinsic valuations
of Bangkok Lab and Cosmetic PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bangkok Lab and Cosmetic PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bangkok Lab and Cosmetic PCL compared to its peers.

Compare the P/E ratios
of Bangkok Lab and Cosmetic PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing Bangkok Lab and Cosmetic PCL with its peers.

Analyze the financial leverage
of Bangkok Lab and Cosmetic PCL compared to its main competitors.

Show all profitability ratios
for Bangkok Lab and Cosmetic PCL.

Provide ROE
for Bangkok Lab and Cosmetic PCL.

Provide ROA
for Bangkok Lab and Cosmetic PCL.

Provide ROIC
for Bangkok Lab and Cosmetic PCL.

Provide ROCE
for Bangkok Lab and Cosmetic PCL.

Provide Gross Margin
for Bangkok Lab and Cosmetic PCL.

Provide Operating Margin
for Bangkok Lab and Cosmetic PCL.

Provide Net Margin
for Bangkok Lab and Cosmetic PCL.

Provide FCF Margin
for Bangkok Lab and Cosmetic PCL.

Show all solvency ratios
for Bangkok Lab and Cosmetic PCL.

Provide D/E Ratio
for Bangkok Lab and Cosmetic PCL.

Provide D/A Ratio
for Bangkok Lab and Cosmetic PCL.

Provide Interest Coverage Ratio
for Bangkok Lab and Cosmetic PCL.

Provide Altman Z-Score Ratio
for Bangkok Lab and Cosmetic PCL.

Provide Quick Ratio
for Bangkok Lab and Cosmetic PCL.

Provide Current Ratio
for Bangkok Lab and Cosmetic PCL.

Provide Cash Ratio
for Bangkok Lab and Cosmetic PCL.

What is the historical Revenue growth
over the last 5 years for Bangkok Lab and Cosmetic PCL?

What is the historical Net Income growth
over the last 5 years for Bangkok Lab and Cosmetic PCL?

What is the current Free Cash Flow
of Bangkok Lab and Cosmetic PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bangkok Lab and Cosmetic PCL.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Bangkok Lab and Cosmetic PCL

Balance Sheet Decomposition
Bangkok Lab and Cosmetic PCL

Current Assets 1.7B
Cash & Short-Term Investments 955.5m
Receivables 347.5m
Other Current Assets 401.1m
Non-Current Assets 508.2m
PP&E 425.7m
Intangibles 9.9m
Other Non-Current Assets 72.6m
Current Liabilities 376.2m
Accounts Payable 107.7m
Short-Term Debt 104.4m
Other Current Liabilities 164.1m
Non-Current Liabilities 220.8m
Long-Term Debt 69.9m
Other Non-Current Liabilities 150.9m
Efficiency

Earnings Waterfall
Bangkok Lab and Cosmetic PCL

Revenue
1.4B THB
Cost of Revenue
-985.4m THB
Gross Profit
449m THB
Operating Expenses
-241.4m THB
Operating Income
207.6m THB
Other Expenses
-51.3m THB
Net Income
156.3m THB

Free Cash Flow Analysis
Bangkok Lab and Cosmetic PCL

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BLC Profitability Score
Profitability Due Diligence

Bangkok Lab and Cosmetic PCL's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Free Cash Flow
Exceptional 1-Year Revenue Growth
59/100
Profitability
Score

Bangkok Lab and Cosmetic PCL's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

BLC Solvency Score
Solvency Due Diligence

Bangkok Lab and Cosmetic PCL's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
83/100
Solvency
Score

Bangkok Lab and Cosmetic PCL's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLC Price Targets Summary
Bangkok Lab and Cosmetic PCL

There are no price targets for BLC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BLC?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BLC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Bangkok Lab and Cosmetic PCL

Country

Thailand

Industry

Pharmaceuticals

Market Cap

3.2B THB

Dividend Yield

2.43%

Description

Bangkok Lab & Cosmetic PCL engaes in the provision of pharmaceuticals and health products. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2023-06-21. The firm is engaged in the production of medicines and health products by selecting raw materials. The firm has produced more than 100 products. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, and Calza-750 TAB FC, among others. Its products are distributed through Bangkok Drug Co., Ltd., Beereach (Thailand) Co., Ltd., Pharmaline Company Limited, Pharma Alliance Company Ltd., and Bangkok Medica Co., Ltd.

Contact

BANGKOK METROPOLIS
Bangkok
Nam Phu Sub-District, Mueang District, Ratchaburi Province, No. 48/1 Nong Chae Sao Road, Moo 5,
+66032719900
bangkoklab.co.th

IPO

2023-06-21

Employees

-

Officers

Chairman of Executive Committee, CEO & Director
Mr. Suvit Ngampoopun
Member of Executive Board & CFO & Director
Mr. Somchai Phisphahutharn
Member of Executive Board, COO & Director
Mr. Subhachai Saibour
Member of Executive Board & Director
Mr. Surasilp Suvit Ngampoopun
Executive Director of Marketing & Member of Executive Committee
Ms. Woranuch Kongsupapsiri
Assistant COO & Member of Executive Committee
Mr. Alongkorn Leela-Uppatikarn
Show More
Executive Director of Support & Member of Executive Committee
Mr. Wongsatorn Ngam-Anak
Executive Director of Manufacture & Member of Executive Committee
Mr. Rachain Sittisang
Executive Director of Accounting & Financial and Member of Executive Committee
Ms. Anuporn Pattravanichkun
Chief Accountant, Assistant CFO & Member of Executive Committee
Ms. Phiraya Chanpatya
Show Less

See Also

Discover More
What is the Intrinsic Value of one BLC stock?

The intrinsic value of one BLC stock under the Base Case scenario is 3.76 THB.

Is BLC stock undervalued or overvalued?

Compared to the current market price of 5.35 THB, Bangkok Lab and Cosmetic PCL is Overvalued by 30%.

Back to Top